Skip to main content
Top
Published in: Breast Cancer Research 1/2002

01-02-2002 | Viewpoint

Centrosome cycle studies reveal promising candidates for anti-cancer drug design

Author: Karen L Schmeichel

Published in: Breast Cancer Research | Issue 1/2002

Login to get access

Excerpt

Centrosomes are complex cellular substructures that are dynamically regulated by a series of biochemical and morphological changes that parallel the progression of the cell cycle. In addition to organizing cytoplasmic microtubule arrays during interphase, centrosomes direct formation and positioning of the bipolar mitotic spindle and thereby enable equal partitioning of chromosomal material during mitosis. Because impaired centrosomal function during cell division has the potential to cause chromosomal missegregation, and thus lead to genetic instability, the centrosome has become an important focus for cancer research. In fact, many tumor cells, including those from the breast, exhibit excessive numbers of centrosomes and/or centrosomes with aberrant morphologies. A collection of recent papers, some of which challenge prevailing dogmas, provide new insight into the biology of the metazoan centrosome cycle (i.e., duplication, maturation and separation) and elucidate novel regulatory pathways that are reasonable targets for oncogenic therapy development. …
Literature
Metadata
Title
Centrosome cycle studies reveal promising candidates for anti-cancer drug design
Author
Karen L Schmeichel
Publication date
01-02-2002
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2002
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr564

Other articles of this Issue 1/2002

Breast Cancer Research 1/2002 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine